🔴 Tvardi Therapeutics is trading 5% down amid broad market weakness

Tvardi Therapeutics is trading at $1.21, with a -5.12% change during the September 28 session, alongside a weaker market.

• The supplied context shows the S&P 500 down 0.83% and Nasdaq down 1.01%.
• Rising oil prices, Treasury yields, and U.S.-Iran tensions are weighing on sentiment.
• No September 28 company-specific catalyst was identified; the company’s latest listed release is dated August 26. The market context is the likeliest explanation, though it does not establish direct causation.